Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CLX
stocks logo

CLX

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.93B
+1.68%
2.196
+20.66%
1.60B
-9.37%
1.549
-16.71%
1.71B
+1.43%
1.548
-0.13%
Estimates Revision
The market is revising Downward the revenue expectations for The Clorox Company (CLX) for FY2025, with the revenue forecasts being adjusted by -0.51% over the past three months. During the same period, the stock price has changed by -6.32%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.51%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.89%
In Past 3 Month
Stock Price
Go Down
down Image
-6.32%
In Past 3 Month
13 Analyst Rating
up Image0
Wall Street analysts forecast CLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLX is 145.42 USD with a low forecast of 134.00 USD and a high forecast of 167.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
9 Hold
3 Sell
Hold
up Image0
Current: 138.060
sliders
Low
134.00
Averages
145.42
High
167.00
up Image0
Current: 138.060
sliders
Low
134.00
Averages
145.42
High
167.00
Barclays
Lauren Lieberman
Sell
Maintains
$134 → $129
2025-05-07
Reason
Barclays
Lauren Lieberman
Price Target
$134 → $129
2025-05-07
Maintains
Sell
Reason
JP Morgan
Andrea Teixeira
Hold
Maintains
$151 → $144
2025-05-06
Reason
JP Morgan
Andrea Teixeira
Price Target
$151 → $144
2025-05-06
Maintains
Hold
Reason
Wells Fargo
Chris Carey
Hold
Maintains
$145 → $142
2025-05-06
Reason
Wells Fargo
Chris Carey
Price Target
$145 → $142
2025-05-06
Maintains
Hold
Reason
Morgan Stanley
Dara Mohsenian
Hold
Maintains
$165 → $150
2025-05-06
Reason
Morgan Stanley
Dara Mohsenian
Price Target
$165 → $150
2025-05-06
Maintains
Hold
Reason
UBS
Peter Grom
Hold
Maintains
$176 → $154
2025-04-17
Reason
UBS
Peter Grom
Price Target
$176 → $154
2025-04-17
Maintains
Hold
Reason
UBS lowered the firm's price target on Clorox to $154 from $176 and keeps a Neutral rating on the shares as part of a Q1 preview for the consumer staples group. With the exception of a few, it is clear the fundamental backdrop has deteriorated in recent weeks, driven by weaker consumer demand and an uncertain tariff backdrop, the analyst tells investors in a research note. UBS thinks the setup into earnings season for staples is "particularly tricky." It continues to favor companies where fundamental visibility is high or improving, irrespective of the stock's valuation. The firm believes Coca-Cola (KO), Keurig Dr Pepper (KDP), Celsius (CELH), Monster Beverage (MNST), and Church & Dwight (CHD) are well positioned heading into earnings.
Wells Fargo
Chris Carey
Hold
Maintains
$155 → $145
2025-04-16
Reason
Wells Fargo
Chris Carey
Price Target
$155 → $145
2025-04-16
Maintains
Hold
Reason
Wells Fargo analyst Chris Carey lowered the firm's price target on Clorox to $145 from $155 and keeps an Equal Weight rating on the shares. The firm is refreshing its global sell-in/sell-through framework one last time before EPS kicks off next week. The final cut of U.S. data is likely to accelerate jitters on consumption, even as emerging market data felt a positive offset for multi-nationals.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Clorox Co (CLX.N) is 19.89, compared to its 5-year average forward P/E of 27.66. For a more detailed relative valuation and DCF analysis to assess Clorox Co 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
27.66
Current PE
19.89
Overvalued PE
32.51
Undervalued PE
22.80

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
18.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
20.39
Undervalued EV/EBITDA
15.61

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.79
Current PS
0.00
Overvalued PS
3.25
Undervalued PS
2.34

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 479.43% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

CLX News & Events

Events Timeline

(ET)
2025-05-12
16:26:11
Clorox names Gina Boswell to its Board of Directors
select
2025-05-08 (ET)
2025-05-08
09:03:09
CloroxPro announces new agreement with Vizient
select
2025-05-05 (ET)
2025-05-05
16:20:45
Clorox reports Q3 gross margin up 240 bps to 44.6% from 42.2% last year
select
Sign Up For More Events
Sign Up For More Events

News

Preview
5.0
04:15 AMNewsfilter
Clorox Announces Election of Gina Boswell to its Board of Directors

  • New Board Member Announcement: The Clorox Company has elected Gina Boswell, CEO of Bath & Body Works, to its board of directors effective May 19, 2025, bringing her extensive experience in consumer goods and public company governance.

  • Company Growth Focus: Clorox's chair and CEO, Linda Rendle, expressed that Boswell's expertise will enhance the company's strategy for growth and innovation, contributing to delivering value for consumers and shareholders.

Preview
5.0
05-12NASDAQ.COM
Monday 5/12 Insider Buying Report: CHDN, CLX

  • Churchill Downs Insider Purchase: Douglas C. Grissom, Director of Churchill Downs, purchased 10,000 shares at $92.77 each for a total of $927,700, currently showing a 7% gain as the stock trades at $99.31.

  • Clorox Insider Purchase: Director Pierre R. Breber bought 4,000 shares of Clorox for $546,285 at $136.57 each, with the stock up about 2.3% on the same day.

Preview
7.0
05-12Reuters
Tariff uncertainty clouds outlook for US television's annual ad-selling bonanza

  • Impact of Tariffs on Advertising: The upcoming U.S. television upfront selling season is overshadowed by concerns over potential tariffs that could lead to a recession, with predictions of a significant drop in ad spending on traditional television and uncertainty affecting brands' advertising budgets.

  • Mixed Outlook for Media Companies: While some companies like Disney and Netflix anticipate growth in ad revenue, others are cautious, with major brands reevaluating their advertising strategies amidst economic uncertainties and the ongoing trade negotiations.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Clorox Co (CLX) stock price today?

The current price of CLX is 138.06 USD — it has increased 2.45 % in the last trading day.

arrow icon

What is Clorox Co (CLX)'s business?

The Clorox Company is a multinational manufacturer and marketer of consumer and professional products. The Company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning, disinfecting and professional products mainly marketed and sold in the United States. The Household segment consists of bags and wraps, cat litter and grilling products marketed and sold in the United States. The Lifestyle segment consists of food, natural personal care products and water-filtration products marketed and sold in the United States. The International consists of products sold outside the United States. The products within International segment include laundry additives; home care products; water-filtration products; digestive health products; grilling products; cat litter; food; bags and wraps; natural personal care products; and professional cleaning and disinfecting products.

arrow icon

What is the price predicton of CLX Stock?

Wall Street analysts forecast CLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLX is 145.42 USD with a low forecast of 134.00 USD and a high forecast of 167.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Clorox Co (CLX)'s revenue for the last quarter?

Clorox Co revenue for the last quarter amounts to 1.67B USD, decreased -8.05 % YoY.

arrow icon

What is Clorox Co (CLX)'s earnings per share (EPS) for the last quarter?

Clorox Co. EPS for the last quarter amounts to 1.50 USD, decreased -465.85 % YoY.

arrow icon

What changes have occurred in the market's expectations for Clorox Co (CLX)'s fundamentals?

The market is revising Downward the revenue expectations for The Clorox Company (CLX) for FY2025, with the revenue forecasts being adjusted by -0.51% over the past three months. During the same period, the stock price has changed by -6.32%.
arrow icon

How many employees does Clorox Co (CLX). have?

Clorox Co (CLX) has 8700 emplpoyees as of May 13 2025.

arrow icon

What is Clorox Co (CLX) market cap?

Today CLX has the market capitalization of 17.02B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free